This site is intended for healthcare professionals only
LoginRegister
Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for EnhertuSubmit Phase IV CT protocol for Entrectinib: CDSCO panel tells Roche India
USFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoeaZydus Gets CDSCO panel Nod for BE Study Of Antineoplastic Drug Relugolix
Re-labelling for price revision not mandatory if drug makers ensure price compliance: NPPARe-labelling for price revision not mandatory if drug makers ensure price compliance: NPPA
Over 15000 Jan Aushadhi Kendras opened till last month under PMBJP scheme across country: MinisterCentre plans to increase number of Janaushadhi Kendras to 10,000 by March 2024
India seeks to boost drug exports to semi regulated markets in Africa, Latin America, Southeast AsiaIndia monitoring pharma exports to China amid COVID surge: Source
Lumpy skin disease vaccine: Govt collaborates with Institute of Veterinary Biological Products for commercial production of Lumpi-ProVacLumpy skin disease vaccine: Govt collaborates with Institute of Veterinary Biological Products for...
Novartis opens new radioligand therapy manufacturing facility in CaliforniaNovartis gets CDSCO Panel nod to market anticancer drug Trametinib and Dabrafenib for additional...
CDSCO Panel Asks Pure and Cure Healthcare To Revise Phase III Protocol of Tapinarof CreamPure & Cure Healthcare secures CDSCO Panel nod for Phase 4 CT of Ivabradine,Metoprolol Tartrate FDC
USFDA grants appeal for Ardelyx XPHOZAHUSFDA grants appeal for Ardelyx XPHOZAH
MediWound bags USFDA nod for NexoBrid to treat severe thermal burns in adultsMediWound bags USFDA nod for NexoBrid to treat severe thermal burns in adults
Novavax begins Phase 2 trial for COVID-Influenza Combo, influenza stand-alone vaccinesNovavax begins Phase 2 trial for COVID-Influenza Combo, influenza stand-alone vaccines
AstraZeneca to Invest USD 15 Billion in China by 2030AstraZeneca Calquence gets Japenese nod for treatment-naïve chronic lymphocytic leukaemia
X